Showing results (241-250 of 264) with videos related to

Sort By:
Pageof 27
Frontiers in Endocrinology|October 3, 2022
Factors associated with therapeutic response in acromegaly diagnosed in the elderly in SpainBetina Biagetti, Pedro Iglesias, Rocío Villar-Taibo, et al.
European Journal of Nutrition|June 10, 2022
Recommendation on an updated standardization of serum magnesium reference rangesAndrea Rosanoff, Christina West, Ronald J Elin, et al.
Clinical Endocrinology|January 14, 2026
Sex- and Age-Specific Metabolic Outcomes of Prolactin Normalisation in HyperprolactinaemiaPedro Iglesias, María Dolores Moure Rodríguez, Fernando Guerrero-Pérez, et al.
Journal of Endocrinological Investigation|December 3, 2025
Efficacy and safety of osilodrostat in patients with ectopic Cushing´s syndrome. a real-world study in SpainMarta Araujo-Castro, Rogelio Garcia-Centeno, Laura González Fernández, et al.
Journal of Clinical Medicine|November 13, 2025
Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in SpainMarta Araujo-Castro, Rogelio García-Centeno, Laura González, et al.
Nature Communications|October 19, 2017
Demographic history and biologically relevant genetic variation of Native Mexicans inferred from whole-genome sequencingSandra Romero-Hidalgo, Adrián Ochoa-Leyva, Alejandro Garcíarrubio, et al.
The Journal of Clinical Endocrinology and Metabolism|September 19, 2024
Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter StudyBetina Biagetti, Esteban Cordero Asanza, Carlos Pérez-López, et al.
Neurosurgery|December 5, 2024
Trends and Outcomes in Pituitary Apoplexy Management: A Spanish Observational Multicenter StudyBetina Biagetti, Esteban Cordero Asanza, Pablo García-Feijoo, et al.
Journal of Clinical & Translational Endocrinology|June 9, 2025
Predictors of conversion to surgery in pituitary apoplexy: Insights from a Spanish multicenter observational studyBetina Biagetti, Esteban Cordero Asanza, Carlos Pérez-López, et al.
Pageof 27